Title : [Treatment strategy for refractory inflammatory bowel disease to improve endoscopic lesions and long-term prognosis].

Pub. Date : 2012

PMID : 22576566






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Recently, new immunomodulators and anti-TNFa agents, such as tacrolimus, infliximab, and adalimumab have been developed and these treatments are available to be treated for patients with refractory UC and CD. Tacrolimus tumor necrosis factor Homo sapiens